Edition:
India

Genomic Health Says German Federal Joint Committee Issues Positive Reimbursement Decision For Oncotype DX Breast Recurrence Score Test


Thursday, 20 Jun 2019 

June 20 (Reuters) - Genomic Health Inc ::GERMAN FEDERAL JOINT COMMITTEE (G-BA) ISSUES EXCLUSIVE NATIONWIDE REIMBURSEMENT DECISION FOR ONCOTYPE DX BREAST RECURRENCE SCORE® TEST.GENOMIC HEALTH - GERMAN FEDERAL JOINT COMMITTEE ISSUED A POSITIVE REIMBURSEMENT DECISION FOR ONCOTYPE DX BREAST RECURRENCE SCORE TEST.GENOMIC HEALTH INC - ONCOTYPE DX WILL BE ONLY MULTIGENE TEST REIMBURSED BY STATUTORY SICK FUNDS WITH WIDE NATIONAL COVERAGE. 

Company Quote

56.9
0.93 +1.66%
10:41pm IST